Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Shanghai Fosun Pharma has long followed an audacious...
Colorcon, a privately held US CRO/CMO excipient maker...
Benitec Biopharma of Australia announced it will pay $4.5...
A giant gastric cancer screening study, which will test...
WuXi PharmaTech, China's largest CRO/CMO, formally...
Roche will acquire GeneWEAVE BioSciences, a US...
Anpac Bio-Medical Science Co. of Shanghai announced that...
Ascletis Pharma, a Hangzhou clinical-stage novel biotech,...
Jiangsu Hengrui Medicine out-licensed global rights...
RuiYi, Inc., a San Diego-Shanghai biotech, has begun a...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China